Skip to main content
Log in

The phenylpropionic acid load test: Experience with 72 children at-risk for ß-oxidation disorders

  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

The urinary excretion of metabolites of orally administered phenylpropionic acid (PPA) in 72 children, aged 2 days to 16 years, thought to be at-risk of medium acyl CoA dehydrogenase deficiency has been studied. Forty had presented as Reye Syndrome, 9 as a Reye-like syndrome and 24 were sibs of deceased RS, sibs of RLS cases or sibs of infants who had died suddenly and without explanation where an autopsy revealed the presence of very heavy fatty infiltration of the liver. These studies demonstrated that PPA metabolites are maximally excreted during the 3 hours following the oral load and that this urine collection should be diagnostic. PPA loading is a relatively simple, safe test which is part of the investigation of a patient suspected of having an inborn error of metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anon. Sudden Infant Death and Inherited Disorders of Fat Oxidation. (Editorial). Lancet 1986: ii, 1073–5.

  2. Pollitt, R. J. Inherited disorders of straight chain fatty acid oxidation. Arch Dis. Child. 1987: 62, 6–7.

    Article  PubMed  CAS  Google Scholar 

  3. Rumsby, G., Seakins, J. W. T., Leonard, J. V. A simple screening test for medium chain acyl CoA dchydrogenase deficiency. Lancet 1986: ii, 467 (Letter).

  4. Seakins, J. W. T., Rumsby, G. The use of phenylpropionic acid as a loading test for medium chain acyl-CoA dehydrogenase deficiency. J. Inherit. Metab. Dis. 1988: 11. (Suppl. 2), 221–4.

    Article  PubMed  Google Scholar 

  5. Moore, R., Millington, D. S., Norwood, D.etal. Identification of phenylpropionyl camitine, a new metabolite of phenylpropionic acid, in a patient with medium chain acyl-CoA dehydrogenase deficiency. J. Inherit. Metab. Dis. 1990: 13, 325–29.

    Article  PubMed  CAS  Google Scholar 

  6. Hall, S., Bellman, M. Reye’s Syndrome in the British Isles: First annual report of the joint British Paediatric Association and Communicable Disease Surveillance Centre Surveillance Scheme. Br. Med. J. 1984: 288, 548–60.

    CAS  Google Scholar 

  7. Roe, C. R., Millington, D. S., Maltby, D. A. Recognition of medium chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden death or Reye-like syndromes. J. Pediatr. 1986: 108, 13–18.

    Article  PubMed  CAS  Google Scholar 

  8. Bennett, M. J., Variend, S., Pollitt, R. J. Screening siblings for inborn errors of fatty acid metabolism in families with a history of sudden infant death. Lancet 1986: ii, 1470 (Letter).

  9. Rumsby, G. Belloque, J., Ersser, R. S.et al. Effect of temperature and sample preparation on performance of ion moderated partition chromatography of organic acids in biologcial fluids. Clin. Chim. Acta 1987: 163, 171–83.

    Article  PubMed  CAS  Google Scholar 

  10. Duran, M., van Vossen, R., Bruinvis, L. The fate of orally ingested 3-phenylpropionic acid. In: Tanaka, K., Coates, P. M. (eds.). Progress in Clinical and Biological Research, vol. 321: Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. Liss, New York, 1990: pp. 419–26.

    Google Scholar 

  11. Wanders, R. J., Ijlst, L., van Gennip, A. H.et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta oxidation. J. Inherit. Metab. Dis. 1990: 13, 311–14.

    Article  PubMed  CAS  Google Scholar 

  12. Anon. Reye Syndrome 1988/89 Update. Communicable Disease Report 1990: 90/09, 4.

  13. Anon. (1987). British Paediatric Surveillance Unit (BPSU)/CDSC Reye’ s Syndrome Surveillance Scheme - Fourth Summary Surveillance Report. Communicable Disease Report 1987: 87/38, 3–6.

  14. Hurwitz, E. S. The changing epidemiology of Reye’ s syndrome in the United States: further evidence of a public health success. J. Am. Med. Ass. 1988: 260, 3178–80.

    Article  CAS  Google Scholar 

  15. Hall, S. M. British Paediatric Surveillance Unit (BPSU)/CDSC Reye’ s Syndrome Surveillance Scheme - Update. Communicable Disease Report 1989: 89/38, 3.

    Google Scholar 

  16. Bennett, M. J., Allison, F., Pollitt, R. J.et al. Fatty acid oxidation defects as causes of unexpected death in infancy. In: Tanaka, K., Coates, P. M. (eds.). Progress in Clinical and Biological Research, vol. 321: Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects. Liss, New York, 1990: pp. 349–364.

    Google Scholar 

  17. Gregersen, N., Lauritzon, R., Rasmussen, K. Suberyl-glycine excretion in the urine of a patient with dicarboxylic aciduria. Clin. Chim. Acta 1976: 70, 417–25.

    Article  PubMed  CAS  Google Scholar 

  18. Matsubara, Y., Narisawa, K., Miyabayashi, S.et al. Identification of a common mutation in patients with MCAD deficiency. Biochem. Biophys. Res. Commun. 1990: 171, 498–505.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glasgow, J.F.T., Moore, R., Robinson, P.H. et al. The phenylpropionic acid load test: Experience with 72 children at-risk for ß-oxidation disorders. I.J.M.S. 161, 586–588 (1992). https://doi.org/10.1007/BF02942363

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02942363

Keywords

Navigation